Screener

Genedata Screener is a comprehensive digital platform designed to automate assay analysis, validate raw data and assay result quality, and consolidate assay information across enterprises and external collaborators. By integrating complex experimental data, it accelerates project decisions and supports predictive, AI-powered drug discovery and development.

The platform accommodates results for any therapeutic modality, including biotherapeutics and small molecules, and covers a wide range of assay technologies with scientifically validated solutions. It allows for centralized workflow specification, harmonizing analysis processes.

Genedata Screener supports scalable screening from primary screening to hit validation and lead development, utilizing biochemical, biophysical, and cellular assays, as well as advanced screening modalities like high-throughput mass spectrometry. It offers end-to-end automation, enhancing the speed, efficiency, and insightfulness of screening processes.

In large molecule research, Genedata Screener accelerates discovery by supporting key assays across workflows, including plate-based immunoassays, cellular assays, high-throughput flow cytometry, epitope binning, and biophysical assays such as surface plasmon resonance (SPR) and bio-layer interferometry (BLI).

For image-based high-content screening (HCS), the platform provides an end-to-end solution that simplifies data interpretation and enables consistent application across the discovery pipeline, unlocking new therapeutic insights.

Genedata Screener also facilitates comprehensive analysis of complex assays, handling multiplexed assays that generate numerous measurements per sample. It streamlines quality control and analysis of multidimensional results from assays like flow cytometry, transcriptomic profiling, and combination screening.

The platform simplifies the analysis of molecular interactions and stability using biophysical screening technologies such as impedance, SPR, BLI, and thermal shift assay (TSA). It offers ready-to-use workflows that eliminate repetitive tasks and enable seamless data integration across plates and instruments.

Additionally, Genedata Screener supports in vitro ADME-Tox and mechanism-of-action studies, enabling rigorous pharmacological and mechanistic analysis to mitigate risks in early drug discovery.